1. Home
  2. PRFX vs DRCT Comparison

PRFX vs DRCT Comparison

Compare PRFX & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$2.63

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.60

Market Cap

1.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRFX
DRCT
Founded
2007
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PRFX
DRCT
Price
$2.63
$0.60
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
344.5K
98.8K
Earning Date
03-26-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$34,694,000.00
Revenue This Year
N/A
$58.20
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.04
52 Week High
$3.71
$6.04

Technical Indicators

Market Signals
Indicator
PRFX
DRCT
Relative Strength Index (RSI) 56.63 28.86
Support Level $1.28 $0.34
Resistance Level $2.91 $0.61
Average True Range (ATR) 0.30 0.09
MACD 0.05 -0.00
Stochastic Oscillator 75.08 8.60

Price Performance

Historical Comparison
PRFX
DRCT

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

Share on Social Networks: